human glucocerebrosidase gene into autologous peripheral blood stem cells

Cell therapyexperimental

Clinical trial activity

1 trials · 3 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0

Earliest trial started Nov 1, 1999 (NCT00004294)

Timeline

1990s

  1. Jan 1, 1999

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • BloodSupplementation

    Blood supplementation

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • human glucocerebrosidase gene into autologous peripheral blood stem cells

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00004294Phase 1Nov 1, 1999National Center for Research Resources (NCRR), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), University of Pittsburgh
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (3)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
National Center for Research Resources (NCRR)Government1111999
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Government1011999
University of PittsburghAcademic/Hospital1011999
3 organizations
Page 1 / 1